TNFSF10 and cancer: Some cell types are resistant to TRAIL-induced apoptosis [11], either because of a particular TRAIL receptor profile [12], through mutations affecting the mitochondrial apoptosis pathway in some type II cancer cells [13], mutations in Akt, or constitutively active NF-κB, c-FLIP or XIAP expression [14-17].